Outlook Therapeutics, Inc. (OTLK)

NASDAQ: OTLK · Real-Time Price · USD

0.6405

-0.0260 (-3.90%)

At close: Sep 8, 2026, 4:00 PM EDT

0.6440

-0.0225 (-3.38%)

Pre-market: Sep 9, 2026, 8:02 AM EDT

Outlook Therapeutics Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	-1.16	1.41	-	-	-	-
Revenue Growth	-	-	-	-	-	-
Cost of Revenue	1.11	1.36	-	26.45	42.33	38.96
Gross Profit	-2.28	0.06	-	-26.45	-42.33	-38.96
Selling, General & Admin	36	39.94	29.94	26.67	20.74	12.77
Research & Development	17.36	27.18	41.76	-	-	-
Operating Expenses	53.36	67.12	71.7	26.67	20.74	12.77
Operating Income	-55.64	-67.06	-71.7	-53.13	-63.07	-51.73
Interest Expense	-0.26	-0.28	-3.16	-2.53	-1.49	-0.94
Interest & Investment Income	0.09	0.09	0.91	0.97	-	-
Earnings From Equity Investments	-0.17	-0.14	-0.1	-0.01	-0.05	-0.05
Other Non Operating Income (Expenses)	0.03	9.49	1.15	0.05	0.47	-0.45
EBT Excluding Unusual Items	-55.95	-57.9	-72.91	-54.65	-64.14	-53.16
Other Unusual Items	-6.73	-6.07	-2.46	-4.33	-1.91	-
Pretax Income	-62.68	-63.98	-75.36	-58.98	-66.05	-53.16
Income Tax Expense	-1.55	-1.55	0	0	0	0
Earnings From Continuing Operations	-61.12	-62.42	-75.37	-58.98	-66.05	-53.16
Net Income	-61.12	-62.42	-75.37	-58.98	-66.05	-53.16
Net Income to Common	-61.12	-62.42	-75.37	-58.98	-66.05	-53.16
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	82	35	19	13	11	8
Shares Outstanding (Diluted)	82	35	19	13	11	8
Shares Change	182.49%	87.59%	48.29%	17.96%	38.91%	110.43%
EPS (Basic)	-0.75	-1.79	-4.06	-4.72	-6.23	-6.96
EPS (Diluted)	-0.75	-1.79	-4.06	-4.72	-6.23	-6.96
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Free Cash Flow	-56.15	-51.83	-68.79	-42.97	-56.67	-54.25
Free Cash Flow Per Share	-0.69	-1.49	-3.71	-3.44	-5.34	-7.11
Gross Margin	-	4.05%	-	-	-	-
Operating Margin	-	-4744.25%	-	-	-	-
Profit Margin	-	-4416.22%	-	-	-	-
Free Cash Flow Margin	-	-3666.65%	-	-	-	-
EBITDA	-55.53	-66.94	-71.59	-53.08	-62.87	-51.46
D&A For EBITDA	0.1	0.12	0.11	0.04	0.2	0.26
EBIT	-55.64	-67.06	-71.7	-53.13	-63.07	-51.73

SEC Filings: 10-K · 10-Q